Indaptus Therapeutics, Inc.
INDPNasdaqCIK 1857044HealthcareFiscal year ends Dec 31
Reports and events: 138 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2025-07-0108:38 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-017283 |
| 2025-06-2617:15 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-016694 |
| 2025-06-2316:37 ET | DEF 14A | Proxy statementPeriod 2025-06-23 | 0001641172-25-016071 |
| 2025-06-1308:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-014972 |
| 2025-06-1116:01 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001641172-25-014689 |
| 2025-05-1408:01 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001641172-25-010099 |
| 2025-05-1408:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-010098 |
| 2025-04-2816:15 ET | DEF 14A | Proxy statementPeriod 2025-04-28 | 0001641172-25-006429 |
| 2025-03-1307:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-010138 |
| 2025-03-1307:30 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001493152-25-010136 |
| 2025-02-1211:38 ET | S-1 | Registration statement | 0001493152-25-006068 |
| 2025-02-1209:22 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-006052 |
| 2025-01-3116:15 ET | 8-K | 3.01 Delisting notice | 0001493152-25-004428 |
| 2025-01-1416:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-002145 |
| 2024-12-2316:52 ET | S-1 | Registration statement | 0001493152-24-051850 |
| 2024-11-2616:11 ET | SC 13D/A | Ownership report, active investor, amended | 0001493152-24-047805 |
| 2024-11-2216:48 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-047422 |
| 2024-11-1208:05 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001493152-24-044537 |
| 2024-11-1208:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-044533 |
| 2024-10-2208:05 ET | 8-K | 8.01 Other events | 0001493152-24-041886 |
| 2024-10-1016:10 ET | SC 13D | Ownership report, active investor | 0001493152-24-040734 |
| 2024-09-1216:45 ET | S-1 | Registration statement | 0001493152-24-036059 |
| 2024-08-1208:01 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001493152-24-031158 |
| 2024-08-1208:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-031157 |
| 2024-08-0808:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-030671 |
| 2024-06-0716:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-24-023119 |
| 2024-05-2208:00 ET | 8-K | 8.01 Other events | 0001493152-24-020966 |
| 2024-05-0808:06 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001493152-24-018162 |
| 2024-05-0808:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-018161 |
| 2024-04-2609:00 ET | DEF 14A | Proxy statementPeriod 2024-04-26 | 0001493152-24-016072 |
| 2024-03-2508:31 ET | 8-K | 8.01 Other events | 0001493152-24-011080 |
| 2024-03-1308:02 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001493152-24-009769 |
| 2024-03-1308:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-009766 |
| 2024-03-0411:01 ET | 8-K | 8.01 Other events | 0001493152-24-008670 |
| 2024-01-2316:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-24-003441 |
| 2023-11-0616:06 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001493152-23-039523 |
| 2023-11-0616:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-039517 |
| 2023-11-0608:13 ET | 8-K | 8.01 Other events | 0001493152-23-039445 |
| 2023-10-3109:12 ET | 8-K | 8.01 Other events | 0001493152-23-038800 |
| 2023-08-1408:15 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001493152-23-028059 |
| 2023-08-1408:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-028054 |
| 2023-08-1008:45 ET | 8-K | 8.01 Other events | 0001493152-23-027463 |
| 2023-05-2516:05 ET | 8-K | 5.07 Shareholder vote results | 0001493152-23-019073 |
| 2023-05-1107:10 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001493152-23-016268 |
| 2023-05-1107:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-016267 |
| 2023-04-1208:00 ET | DEF 14A | Proxy statementPeriod 2023-04-12 | 0001493152-23-011938 |
| 2023-03-2308:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001493152-23-008636 |
| 2023-03-1708:05 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001493152-23-008010 |
| 2023-03-1708:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-008009 |
| 2023-02-1408:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-23-004613 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 21:10 ET. Listed shows no prices and gives no investment advice.